Showing results (191-200 of 242) with videos related to

Sort By:
Pageof 25
Blood|April 22, 2004
Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphomaDavid A Rizzieri, Gamal Akabani, Michael R Zalutsky, et al.
Plos One|September 17, 2013
Induction of the unfolded protein response drives enhanced metabolism and chemoresistance in glioma cellsLaura M Epple, Rebecca D Dodd, Andrea L Merz, et al.
Molecular Cancer Research : MCR|February 3, 2017
Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor ProgressionChristopher J Pirozzi, Austin B Carpenter, Matthew S Waitkus, et al.
The New England Journal of Medicine|June 27, 2018
Recurrent Glioblastoma Treated with Recombinant PoliovirusAnnick Desjardins, Matthias Gromeier, James E Herndon, et al.
Plos One|March 3, 2012
A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastomaJohn H Sampson, Robert J Schmittling, Gary E Archer, et al.
Molecular Cancer Therapeutics|January 20, 2005
Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibitionRanjit K Goudar, Qing Shi, Mark D Hjelmeland, et al.
Cancer Research|November 4, 2017
Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1<sup>R132H</sup>-Induced Metabolic LiabilitiesMatthew S Waitkus, Christopher J Pirozzi, Casey J Moure, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2010
Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastomaJohn H Sampson, Amy B Heimberger, Gary E Archer, et al.
Blood|July 20, 2011
Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humansDuane A Mitchell, Xiuyu Cui, Robert J Schmittling, et al.
Cancer Cell|January 15, 2016
MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1BJing Hu, Tao Sun, Hui Wang, et al.
Pageof 25